Want to see AMN full AI Analyst Report?
Operating Income by Segment
Highlights which segments are truly profitable after operating costs, helping you see where AMN earns healthy margins versus where growth comes at a higher cost; large disparities can signal strategic focus areas or segments that may drag overall earnings.Nurse & Allied’s operating income surge in the March 2026 quarter reflects one‑off labor‑disruption revenue and rapid‑response margins, masking a multi‑quarter decay in Physician & Leadership and Technology & Workforce profitability driven by pricing, volume and competitive pressure; unallocated corporate overhead remains a steady drag. Management explicitly warns much of Q1’s event revenue won’t recur and guided conservatively for Q2, so consolidated operating income is likely to normalize lower unless core demand recovers or technology/AI initiatives materially accelerate margin improvement.
Date | Nurse and Allied Solutions | Physician and Leadership Solutions | Technology and Workforce Solutions | Unallocated Corporate Overhead |
|---|---|---|---|---|
Jun 30, 2026 | $58.24M | $11.05M | $24.62M | -$20.55M |
Mar 31, 2026 | $153.33M | $10.82M | $25.27M | -$23.29M |
Dec 31, 2025 | $36.48M | $12.92M | $24.90M | -$19.82M |
Sep 30, 2025 | $28.76M | $15.73M | $30.89M | -$17.87M |
Jun 30, 2025 | $28.48M | $13.49M | $35.21M | -$18.89M |
Mar 31, 2025 | $32.24M | $14.46M | $35.25M | -$17.75M |
Dec 31, 2024 | $38.93M | $17.03M | $40.28M | -$21.12M |
Sep 30, 2024 | $35.11M | $18.13M | $41.95M | -$21.32M |
Jun 30, 2024 | $46.21M | $21.66M | $47.26M | -$21.04M |
Mar 31, 2024 | $53.34M | $22.22M | $44.27M | -$22.17M |